Recent Updates
Recently added Catalysts

CBN and CBD

Phase 2

Healthy Adults | Unknown | Other |Canopy Growth Corporation Common Shares|Last Updated: May 2, 2023

Success Probability
Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
Premium
Market & Valuation
rNPV $3.2B
Market Size $9.4B
Revenue Basis $1.6B
Competitors 6
Premium
Trial Design
UNCONTROLLED
Total Trials1
Total Enrollment301
FDA Designations
No designations recorded
Clinical Trials (1)
NCT IDTitlePhaseStatusEnrollmentVelocityDesignStartCompletionLast UpdatedSitesCountries
NCT05839964A Double-Blind, Randomized, Placebo-Controlled Study of the Safety and Effects of CBN With and Without CBD on Sleep QualityPHASE1/PHASE2 COMPLETED 301May 1, 2022Dec 1, 2022May 2, 2023 -
Unlock Drug Trial Details
Study Design & Arms
Interventions
NameTypeDescription
CBN and CBDDIETARY_SUPPLEMENTCBN and CBD in Gummy Format
Unlock Study Design Details